NCT02535078 · Interventional trial
Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma
Overall registry status Withdrawn
Phase 1 · Phase 2
Conditions Malignant Melanoma
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory